MONJUVI Trademark

Trademark Overview


On Friday, August 10, 2018, a trademark application was filed for MONJUVI with the United States Patent and Trademark Office. The USPTO has given the MONJUVI trademark a serial number of 88074194. The federal status of this trademark filing is REGISTERED as of Tuesday, April 14, 2020. This trademark is owned by MorphoSys AG. The MONJUVI trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; cl...

Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development ser...
monjuvi

General Information


Serial Number88074194
Word MarkMONJUVI
Filing DateFriday, August 10, 2018
Status700 - REGISTERED
Status DateTuesday, April 14, 2020
Registration Number6031814
Registration DateTuesday, April 14, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2019

Trademark Statements


Goods and ServicesPharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; none of the foregoing goods for use in connection with the treatment or prevention of ear disorders
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 20, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 20, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameINCYTE HOLDINGS CORPORATION
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressWILMINGTON, DE 19803

Party NameMorphoSys AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressPlanegg D-82152
DE

Party NameMorphoSys AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressPlanegg D-82152
DE

Party NameMorphoSys AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressPlanegg D-82152
DE

Trademark Events


Event DateEvent Description
Thursday, November 15, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, August 14, 2018NEW APPLICATION ENTERED
Monday, August 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, September 9, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, September 18, 2018ASSIGNED TO LIE
Tuesday, September 18, 2018PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, November 20, 2018PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, November 28, 2018ASSIGNED TO EXAMINER
Tuesday, December 4, 2018NON-FINAL ACTION WRITTEN
Tuesday, December 4, 2018NON-FINAL ACTION E-MAILED
Tuesday, December 4, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 31, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 31, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, June 1, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 10, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 10, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, July 16, 2019PUBLISHED FOR OPPOSITION
Monday, June 10, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, June 10, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, June 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 26, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 22, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, July 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, July 22, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, November 20, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, November 18, 2019ASSIGNED TO PETITION STAFF
Monday, January 13, 2020OPPOSITION INSTITUTED NO. 999999
Saturday, March 7, 2020OPPOSITION TERMINATED NO. 999999
Saturday, March 7, 2020TTAB RELEASE CASE TO TRADEMARKS
Saturday, March 7, 2020OPPOSITION DISMISSED NO. 999999
Tuesday, April 14, 2020REGISTERED-PRINCIPAL REGISTER
Monday, June 17, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 17, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 1, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, April 24, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY